Bill
HR 629
The Ending Chemical Abortions Act of 2025 prohibits chemical abortion drugs, limiting options for women and impacting healthcare providers and pharmaceutical companies.
Bill Number: HR 629
Title: Ending Chemical Abortions Act of 2025
Status: Introduced in House
Introduced Date: January 22, 2025
Classification: Bill
The Ending Chemical Abortions Act of 2025 aims to prohibit the use of chemical abortion methods in the United States. The bill seeks to address concerns regarding the safety and accessibility of chemical abortion drugs, which are used to terminate pregnancies in the early stages. Proponents of the bill argue that it is necessary to protect the health and safety of women, while opponents contend that it restricts reproductive rights.
The bill includes several significant provisions:
Prohibition of Chemical Abortions: The legislation would make it illegal to prescribe or administer chemical abortion drugs, including mifepristone and misoprostol, for the purpose of terminating a pregnancy.
Exceptions: The bill may outline specific exceptions, such as cases where the mother's life is at risk, but these details are not specified in the current version.
Penalties: The bill may impose penalties on healthcare providers who violate the prohibition, although specific penalties are not detailed in the introduced version.
Regulatory Changes: The bill could require changes to existing regulations surrounding abortion services and the distribution of related medications.
Women Seeking Abortions: The primary impact would be on women who seek to terminate pregnancies through chemical methods, limiting their options for abortion care.
Healthcare Providers: Physicians, pharmacists, and healthcare facilities that currently provide chemical abortion services would be directly affected by the prohibition.
Pharmaceutical Companies: Companies that manufacture and distribute chemical abortion drugs may face significant changes in their operations and market dynamics.
Committee Review: Following its introduction on January 22, 2025, HR 629 was referred to the House Committee on the Judiciary for further consideration. The committee will review the bill, hold hearings, and may make amendments before it is brought to the House floor for a vote.
Legislative Process: If the bill passes the committee stage, it will proceed to the full House for debate and voting. If approved, it will then move to the Senate for consideration.
Public Engagement: As the bill progresses, there may be opportunities for public comment and advocacy from both supporters and opponents of the legislation.
The Ending Chemical Abortions Act of 2025 represents a significant legislative effort to restrict access to chemical abortion methods in the United States. As the bill moves through the legislative process, it will likely generate considerable debate regarding women's reproductive rights and healthcare access.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
